New Zealand markets closed

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.30-0.12 (-2.21%)
At close: 04:00PM EDT
5.26 -0.04 (-0.75%)
After hours: 04:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 166.97M
Enterprise value 129.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.64
Price/book (mrq)7.39
Enterprise value/revenue 6.69
Enterprise value/EBITDA -3.14

Trading information

Stock price history

Beta (5Y monthly) 4.07
52-week change 326.49%
S&P500 52-week change 326.27%
52-week high 38.22
52-week low 32.68
50-day moving average 35.87
200-day moving average 34.76

Share statistics

Avg vol (3-month) 3329.23k
Avg vol (10-day) 3238.35k
Shares outstanding 531.5M
Implied shares outstanding 631.5M
Float 826M
% held by insiders 18.34%
% held by institutions 122.03%
Shares short (30 Apr 2024) 44.14M
Short ratio (30 Apr 2024) 410.91
Short % of float (30 Apr 2024) 415.85%
Short % of shares outstanding (30 Apr 2024) 413.15%
Shares short (prior month 28 Mar 2024) 43.5M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -88.52%
Operating margin (ttm)-10.60%

Management effectiveness

Return on assets (ttm)-27.66%
Return on equity (ttm)-129.63%

Income statement

Revenue (ttm)25.18M
Revenue per share (ttm)0.94
Quarterly revenue growth (yoy)1,159.30%
Gross profit (ttm)N/A
EBITDA -23.01M
Net income avi to common (ttm)-22.29M
Diluted EPS (ttm)-0.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.49M
Total cash per share (mrq)1.26
Total debt (mrq)2.24M
Total debt/equity (mrq)9.89%
Current ratio (mrq)1.63
Book value per share (mrq)0.73

Cash flow statement

Operating cash flow (ttm)-25.6M
Levered free cash flow (ttm)-10.92M